Alumni, PhD
- Benita Sjögren (PhD, 2008). Involvement of lipid rafts in G protein-coupled monoamine receptor trafficking and signaling : A pharmacological approach
- Xiaoqun Zhang (PhD, 2008). Neuropharmacological studies of Parkinson´s disease with some emphasis on serotonin transmission
- Sven Pålhagen (PhD, 2009). Parkinson´s disease and depression : Clinical and neurobiological studies
- Hongshi Qi (PhD, 2009). Studies on antidepressant-mediated regulation of signal transduction
- Martin Egeland (PhD, 2012). Pharmacological and genetic modulation of adult neurogenesis in animal models relevant to neuropsychiatric disorders
- Carly Kiselycznyk (PhD, 2012). Mediators of synaptic activity in anxiety- and depression-related behaviors
- Mikael Skorpil (PhD, 2012). Nerve diffusion tensor imaging
- Therese M Eriksson (PhD, 2012). Serotonin in emotional memory processes : neuropharmacological studies with emphasis on depression
- Ebba Gregorsson Lundius (PhD, 2013). GPCRs regulating catecholaminergic cell survival and function : focus on GPR37
- Tiberiu Loderan Stan (PhD, 2014). 5-HT receptor-mediated modulation of glutamate transmission in the hippocampus and prefrontal cortex and its relation to cognition and depression
- Stal Saurav Shrestha (PhD, 2014). The role of the serotonergic system and the effects of antidepressants during brain development examined using in vivo PET imaging and in vitro receptor binding
- Alexandra Alvarsson (PhD, 2015). Progressive models of Parkinson’s disease : behavioural and neurochemical analyses
- Martin Paucar (PhD, 2017). Genotype-phenotype characterization of familial hyperkinetic movement disorders : emphasis on ataxia and brain calcifications
- Cyril Monnot (PhD, 2018). Functional MRI characterization of animal models of parkinsonism
- Mark Zurbrügg (Licentiate, 2019). Is modulation of glucocerebrosidase a viable new treatment for Parkinson’s disease?
- Henrik Sjöström (PhD, 2020). Magnetic resonance imaging techniques for diagnostics in Parkinson’s disease and atypical parkinsonism
- Ellen Hertz (PhD, 2020). Translational studies of molecular interactions in Parkinson’s disease
- Ioannis Mantas (PhD, 2022). Regulation of monoaminergic functions by GPCRs with a special emphasis on mental and movement disorders
- Mattias Andréasson (PhD, 2022). Peripheral neuropathy and altered cobalamin metabolism in Parkinson’s disease and other movement
- Panagiota Tsitsi, (PhD, 2022). Studies on eye movements in Parkinson’s disease
- Yachao He, (PhD, 2023). Bridging the gap between lipid dyshomeostasis and brain disorders : role of prosaposin and progranulin
- Shervin Khosousi Fakhrabadi, (PhD, 2023). Discovery of Plasma Biomarkers for Parkinson’s Disease and Associated Cognitive Decline
- Lovisa Brodin, (PhD, 2024). Parkinson’s disease and Gaucher disease : focus on the GBA1 link
- Rika Kojima, (PhD, 2024). Translational studies of glucocerebrosidase in Parkinson´s disease
- Marcus Saarinen, (PhD, 2024). Discrete approaches for leveraging g protein-coupled receptors as therapeutic tools
Alumni, postdocs
- Alexandra Madeira
- Andreas Cederlund
- Dorian Caudal
- Holly Green
- Jean-Ha Baek
- José Laffita Mesa
- Kalicharan Patra
- Karl Björk
- Kristina Bekanovic
- Lina Leinartaité
- Marcela Pereira
- Nicoletta Schintu
- Nikolas Stroth
- Therese Fagerqvist
- Vandana Veenit
- Xavier Morató Arús
- Vesna Lazarevic
- Tianyi Li
- Vasco Sousa (postdoc 2011-2014, senior lab manager 2014-2021)
- Dejan Mamula
- Carl-Fredrik Bowin
- Ellen Appleton